Company / Revenue
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Revenue History
FY2016-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$78.6M
FY2018
5-year range
-
FY2016-FY2018
Trend
-15.9%
vs FY2017
Sector context
#151 of 156
Health Care
What the data says
Among 156 Health Care companies, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is in the bottom 3% for revenue. Declined from $91M to $79M over the past 2 years.
Based on SEC 10-K filings.
$79M in FY2018.
Declined from $91M to $79M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 156This company $78.6M Sector average $19.0B
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2018, revenue decreased 15.9% year-over-year.
- Ranks #151 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $78.6M | -15.9% |
| FY2017 | $93.5M | +3.0% |
| FY2016 | $90.7M | +221.9% |
As of FY2018 · SEC 10-K · Updated Jun 30, 2026